Found 16 results. Export: Tagged | XML
Filters: keyword is Apomorphine  [Clear All Filters]
2005
Li, G.L., de Vries, J.J., van Steeg, T.J., van den Bussche, H., Maas, H.J., Reeuwijk, H.J., Danhof, M., Bouwstra, J.A., van Laar, T. , Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment, J Control Release, vol. 101, no. 1-3, pp. 199-208. DOI
2004
Nugroho, A.K., Della Pasqua, O., Danhof, M., Bouwstra, J.A. , Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application, Pharm Res, vol. 21, no. 11, pp. 1974-84.
2003
Li, G.L., Grossklaus, A., Danhof, M., Bouwstra, J.A. , Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies, Int J Pharm, vol. 266, no. 1-2, pp. 61-8. DOI
Li, G.L., Danhof, M., Frederik, P.M., Bouwstra, J.A. , Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro, Pharm Res, vol. 20, no. 4, pp. 653-9.
2002
Li, G.L., van der Geest, R., Chanet, L., van Zanten, E., Danhof, M., Bouwstra, J.A. , In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement, J Control Release, vol. 84, no. 1-2, pp. 49-57. DOI
2001
Li, G.L., Danhof, M., Bouwstra, J.A. , Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro, Pharm Res, vol. 18, no. 11, pp. 1627-30.
Li, G.L., Danhof, M., Bouwstra, J.A. , Lontophoretic delivery of apomorphine in vitro: physicochemic considerations, Pharm Res, vol. 18, no. 11, pp. 1509-13.
1999
van Laar, T., Van der Geest, R., Danhof, M. , Future delivery systems for apomorphine in patients with Parkinson's disease, Adv Neurol, vol. 80, pp. 535-44.
1998
van der Geest, R., van Laar, T., Kruger, P.P., Gubbens-Stibbe, J.M., Bodde, H.E., Roos, R.A., Danhof, M. , Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease, Clin Neuropharmacol, vol. 21, no. 3, pp. 159-68.
van Laar, T., van der Geest, R., Danhof, M., Bodde, H.E., Goossens, P.H., Roos, R.A. , Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease, Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
van der Geest, R., Danhof, M., Bodde, H.E. , Validation and testing of a new iontophoretic continuous flow through transport cell, J Control Release, vol. 51, no. 1, pp. 85-91. DOI
1997
van der Geest, R., Kruger, P., Gubbens-Stibbe, J.M., van Laar, T., Bodde, H.E., Danhof, M. , Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease, J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
van der Geest, R., Danhof, M., Bodde, H.E. , Iontophoretic delivery of apomorphine. I: In vitro optimization and validation, Pharm Res, vol. 14, no. 12, pp. 1798-803.
van der Geest, R., van Laar, T., Gubbens-Stibbe, J.M., Bodde, H.E., Danhof, M. , Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease, Pharm Res, vol. 14, no. 12, pp. 1804-10.
1996
van Laar, T., Neef, C., Danhof, M., Roon, K. I, Roos, R.A. , A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease, Mov Disord, vol. 11, no. 6, pp. 633-8. DOI
1995
van Laar, T., Jansen, E.N., Neef, C., Danhof, M., Roos, R.A. , Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories, Mov Disord, vol. 10, no. 4, pp. 433-9. DOI